Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
38%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
PJP
31
HOLDINGS
26%
ALSO IN THNR
THNR
18
HOLDINGS
39%
ALSO IN PJP
SECTOR DRIFT (PJP minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 6.1% | 12.2% | 6.1% |
|
GILEAD SCIENCES INC | 6.1% | 5.9% | 5.9% |
|
ABBVIE INC | 5.9% | 5.8% | 5.8% |
|
PFIZER INC | 5.7% | 5.7% | 5.7% |
|
AMGEN INC | 5.6% | 6.3% | 5.6% |
PJP Overweight Relative to THNR
|
JOHNSON & JOHNSON | 5.3% |
|
ABBOTT LABORATORIES | 4.9% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | 3.6% |
|
UNITED THERAPEUTICS CORP | 3.5% |
|
BIOGEN IDEC INC | 3.5% |
|
LIGAND PHARMACEUTICALS-CL B | 3.5% |
|
VIATRIS, INC. | 3.4% |
 |
PERRIGO CO | 3.3% |
|
TARSUS PHARMACEUTICALS, INC. | 3.2% |
|
INNOVIVA, INC. | 3.0% |
PJP Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -8.8% |
|
ELI LILLY & CO | -6.1% |
 |
ASTRAZENECA PLC | -6.1% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -5.1% |
 |
CHINA PHARMACEUTICAL GROUP | -4.5% |
 |
INNOVENT BIOLOGICS, INC. | -4.3% |
|
VIKING THERAPEUTICS, INC. | -4.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.6% |
|
ZEALAND PHARMA A/S | -3.5% |
 |
HANMI PHARM CO LTD | -2.9% |